SCHEMBL6494047

SCHEMBL6494047

CCN(CC)c1cc[c]c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.41
CYP3A4 P08684 4/20 0.41
TERT O14746 1/20 0.41
S100B P04271 1/20 0.40
L3MBTL1 Q9Y468 6/20 0.39
TDP1 Q9NUW8 5/20 0.39
KDM4E B2RXH2 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
GLA P06280 3/20 0.39
TSHR P16473 3/20 0.39
HTT P42858 3/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
TP53 P04637 2/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4006254 0.82 IGLV6-57 (0.34)
SCHEMBL1637760 0.79 S100B (0.47) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL16167543 0.78 ALDH1A1 (0.42) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL3217368 0.77 ALDH1A1 (0.38) ALDH1A1CYP3A4TERTL3MBTL1TDP1
SCHEMBL3654511 0.76 S100B (0.44) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL1637260 0.76 ALDH1A1 (0.50) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL4011698 0.76 DAO (0.31)
SCHEMBL11646609 0.74 ALDH1A1 (0.40) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL28081759 0.73 ALDH1A1 (0.39) ALDH1A1CYP3A4TERTS100BL3MBTL1
SCHEMBL27433894 0.73 S100B (0.42) ALDH1A1CYP3A4TERTS100BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4101540-A USEFUL FOR DYEING ACRYLONITRILE POLYMERS OR ACID-MODIFIED POLYESTERS OR POLYAMIDES PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1978-07-18 US claimed
US-6890934-B2 Sulfonamide compounds and uses thereof as medicines FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-05-10 US disclosed
US-20030171396-A1 Sulfonamide compounds and uses thereof as medicines FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2003-09-11 US disclosed
EP-1136492-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-26 EP disclosed
US-4119776-A Vinyl phthalide color formers NCR CORPORATION (US) 1978-10-10 US disclosed
US-4026883-A MACHINE READABLE AND COPIABLE NCR CORPORATION (US) 1977-05-31 US disclosed
US-4022771-A RECORD MATERIALS AND MARKING SYSTEMS NCR CORPORATION (US) 1977-05-10 US disclosed
US-4016174-A USED IN PRESSURE SENSITIVE RECORD MATERIALS AND MANIFOLD MARKING SYSTEMS NCR CORPORATION (US) 1977-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171396-A1 Sulfonamide compounds and uses thereof as medicines PDE2A, PDE3A, PDE5A ALDH1A1 476/4885CYP3A4 1384/4885TERT 4460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.